Dose-Dependent Effects of Lead Acetate on Cerebral Cortex Cytoarchitecture and Cholinergic–Gabaergic Neurotransmission in Adult Male Wistar Rats

Background: Lead (Pb) remains one of the most pervasive environmental neurotoxicants worldwide, and the developing and adult central nervous system is particularly vulnerable to its dose-dependent effects. Although the cholinergic and oxidative consequences of lead exposure have been documented, the combined histopathological and neurochemical (acetylcholine, acetylcholinesterase, and γ-aminobutyric acid [GABA]) consequences of graded oral lead acetate exposure on the adult cerebral cortex remain incompletely characterised. Methods: Twenty adult male Wistar rats (150–200 g) were randomly allocated into four groups (n = 5/group): a distilled-water control, and three groups administered lead acetate at 100, 200, and 400 mg/kg body weight by oral gavage daily for 21 days. Serum acetylcholine, acetylcholinesterase (AChE) activity, and GABA concentration were measured, and cerebral cortical sections were processed for haematoxylin and eosin (H&E) histology. Data were analysed by one-way ANOVA followed by Duncan's Multiple Range Test (p < 0.05). Results: Lead acetate produced a dose-dependent increase in serum acetylcholine (from ~730 pg/mL in controls to ~970 pg/mL at 400 mg/kg) accompanied by a dose-dependent decline in AChE activity (from ~22 IU/L to ~14.8 IU/L) and GABA concentration (from ~7.1 to ~4.6 µmol/mL), all significant at p < 0.05 relative to control. Histologically, the control cortex showed normal neuropil with ramified, resting microglia and quiescent astrocytes, whereas lead-exposed cortices showed progressive, dose-related microglial activation, astrogliosis, and neuropil vacuolation, culminating in severe neuropil disorganisation and amoeboid microglial transformation at 400 mg/kg. Conclusion: Subacute oral lead acetate exposure produces concurrent, dose-dependent cholinergic dysregulation, GABAergic suppression, and neuroinflammatory histopathology in the adult rat cerebral cortex, supporting a multi-mechanistic model of lead neurotoxicity in which impaired acetylcholine catabolism, loss of inhibitory tone, and glial activation act in concert to compromise cortical integrity.

lead acetate; neurotoxicity; cerebral cortex; acetylcholinesterase; GABA; microglia; Wistar rats

1. Bereda, G. (2026). Global burden of lead exposure: Integrating epidemiology, molecular mechanisms, and mitigation approaches. Health Science Reports, *9*(3), e71952. [Google Scholar] [Crossref]

2. Generalova, A., Davidova, S., & Satchanska, G. (2025). The mechanisms of lead toxicity in living organisms. Journal of Xenobiotics, *15*(5), 146. [Google Scholar] [Crossref]

3. González-Villalva, A., et al. (2025). Lead systemic toxicity: A persistent problem for health. Toxicology, *515*, 154163. [Google Scholar] [Crossref]

4. Peng, D., Wei, P., Li, Z., Wei, R., Li, H., & Li, S. (2025). The role of P62/Nrf2/Keap1 signaling pathway in lead-induced neurological dysfunction. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.70566 [Google Scholar] [Crossref]

5. Kurhaluk, N., et al. (2024). NO system in modulating lead-induced neurotoxicity in rats with different resistance to hypoxia. Cellular Physiology and Biochemistry, *58*, 597–629. [Google Scholar] [Crossref]

6. Shvachiy, L., Amaro-Leal, Â., Outeiro, T. F., Rocha, I., & Geraldes, V. (2023). Intermittent lead exposure induces behavioral and cardiovascular alterations associated with neuroinflammation. Cells, *12*(5), 818. [Google Scholar] [Crossref]

7. Mansour, L. A. H., Elshopakey, G. E., Abdelhamid, F. M., Albukhari, T. A., Almehmadi, S. J., Refaat, B., El-Boshy, M., & Risha, E. F. (2023). Hepatoprotective and neuroprotective effects of naringenin against lead-induced oxidative stress, inflammation, and apoptosis in rats. Biomedicines, *11*(4), 1080. [Google Scholar] [Crossref]

8. Gąssowska-Dobrowolska, M., Chlubek, M., Kolasa, A., Tomasiak, P., Korbecki, J., Skowrońska, K., Tarnowski, M., Masztalewicz, M., & Baranowska-Bosiacka, I. (2023). Microglia and astroglia—the potential role in neuroinflammation induced by pre- and neonatal exposure to lead (Pb). International Journal of Molecular Sciences, *24*(12), 9903. [Google Scholar] [Crossref]

9. Zhu, J., Zhou, F., Zhou, Q., Xu, Y., Li, Y., Huang, D., Chen, L., Liu, A., Zou, F., & Meng, X. (2023). NLRP3 activation in microglia contributes to learning and memory impairment induced by chronic lead exposure in mice. Toxicological Sciences, *191*(1), 179–191. [Google Scholar] [Crossref]

10. Larsen, B., & Sánchez-Triana, E. (2023). Global health burden and cost of lead exposure in children and adults: A health impact and economic modelling analysis. The Lancet Planetary Health, *7*(10), e831–e840. [Google Scholar] [Crossref]

11. Long, X., Wu, H., Zhou, Y., Wan, Y., Kan, X., Gong, J., & Zhao, X. (2022). Preventive effect of Limosilactobacillus fermentum SCHY34 on lead acetate-induced neurological damage in SD rats. Frontiers in Nutrition, *9*, 852012. [Google Scholar] [Crossref]

12. Zhou, N., Huang, Y., Li, M., Zhou, L., & Jin, H. (2022). Trends in global burden of diseases attributable to lead exposure in 204 countries and territories from 1990 to 2019. Frontiers in Public Health, *10*, 1036398. [Google Scholar] [Crossref]

13. Huang, Q., Liao, C., Ge, F., et al. (2022). Acetylcholine bidirectionally regulates learning and memory. Journal of Neurorestoratology, *10*(2), 100002. [Google Scholar] [Crossref]

14. Vidal-Itriago, A., Radford, R. A. W., Aramideh, J. A., Maurel, C., Scherer, N. M., Don, E. K., Lee, A., Chung, R. S., Graeber, M. B., & Morsch, M. (2022). Microglia morphophysiological diversity and its implications for the CNS. Frontiers in Immunology, *13*, 997786. [Google Scholar] [Crossref]

15. Cherubini, E., Di Cristo, G., & Avoli, M. (2022). Dysregulation of GABAergic signaling in neurodevelopmental disorders: Targeting cation-chloride co-transporters to re-establish a proper E/I balance. Frontiers in Cellular Neuroscience, *15*, 813441. [Google Scholar] [Crossref]

16. Michalettos, G., & Ruscher, K. (2022). Crosstalk between GABAergic neurotransmission and inflammatory cascades in the post-ischemic brain: Relevance for stroke recovery. Frontiers in Cellular Neuroscience, *16*, 807911. [Google Scholar] [Crossref]

17. Leão, L. K. R., Bittencourt, L. O., Oliveira, A. C. A., Nascimento, P. C., Ferreira, M. K. M., Miranda, G. H. N., Ferreira, R. O., Eiró-Quirino, L., Puty, B., Dionizio, A., Cartágenes, S. C., Freire, M. A. M., Buzalaf, M. A. R., Crespo-Lopez, M. E., Maia, C. S. F., & Lima, R. R. (2021). Lead-induced motor dysfunction is associated with oxidative stress, proteome modulation, and neurodegeneration in motor cortex of rats. Oxidative Medicine and Cellular Longevity, *2021*, 5595047. [Google Scholar] [Crossref]

18. Ericson, B., et al. (2021). Blood lead levels in low-income and middle-income countries: A systematic review. The Lancet Planetary Health, *5*(3), e145–e153. [Google Scholar] [Crossref]

19. Sears, S. M., & Hewett, S. J. (2021). Influence of glutamate and GABA transport on brain excitatory/inhibitory balance. Experimental Biology and Medicine (Maywood), *246*(9), 1069–1083. [Google Scholar] [Crossref]

20. Lier, J., Streit, W. J., & Bechmann, I. (2021). Beyond activation: Characterizing microglial functional phenotypes. Cells, *10*(9), 2236. [Google Scholar] [Crossref]

21. Fang, Y., Lu, L., Liang, Y., Peng, D., Aschner, M., & Jiang, Y. (2021). Signal transduction associated with lead-induced neurological disorders: A review. Food and Chemical Toxicology, *150*, 112063. [Google Scholar] [Crossref]

22. Virgolini, M. B., & Aschner, M. (2021). Molecular mechanisms of lead neurotoxicity. Advances in Neurotoxicology, *5*, 159–213. [Google Scholar] [Crossref]

23. Abubakar, K., Mailafiya, M. M., Danmaigoro, A., Chiroma, S. M., Rahim, E. B. A., & Zakaria, M. Z. A. B. (2019). Curcumin attenuates lead-induced cerebellar toxicity in rats via chelating activity and inhibition of oxidative stress. Biomolecules, *9*(9), 453. [Google Scholar] [Crossref]

24. Rădulescu, A., & Lundgren, S. (2019). A pharmacokinetic model of lead absorption and calcium competitive dynamics. Scientific Reports, *9*, 14225. [Google Scholar] [Crossref]

25. Sahin, Z., Ozkaya, A., Uckun, M., Yologlu, E., Kuzu, M., Comakli, V., Demirdag, R., Tel, A. Z., Aymelek, F., & Yologlu, S. (2019). Evaluation of the effects of Cyclotrichium niveum on brain acetylcholinesterase activity and oxidative stress in male rats orally exposed to lead acetate. Cellular and Molecular Biology (Noisy-le-grand), *65*(5), 3–8. [Google Scholar] [Crossref]

26. Abdel Moneim, A. E. (2016). Indigofera oblongifolia prevents lead acetate-induced hepatotoxicity, oxidative stress, fibrosis and apoptosis in rats. PLOS ONE, *11*(7), e0158965. [Google Scholar] [Crossref]

• Tribal Child Nutrition and Health in District of Sundargarh: A Public Health Review of ICDS Intervention
• Knowledge, Attitudes and Practices Towards Prostate Cancer Screening Amongst Men Aged 40-60 Years in The Buea Health District: A Cross-Sectional Study
• Compliance with JCI Protocols: A Focus on Employee Safety
• Influence and Involvement of Teachers in Menstrual Hygiene Management of Female Secondary School Students in Kogi State, Nigeria
• A Critical Evaluation of Ayushman Bharat Pradhan Mantri Jan Arogya Yojana in Bihar